Sarepta Therapeutics, Inc. (SRPT) Social Stream
SAREPTA THERAPEUTICS INC (SRPT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SAREPTA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 17 | $160 | $90 | $127.25 | $122.69 | 3.72% |
| 2021-12-26 | 16 | $160 | $90 | $127.076 | $122.69 | 3.57% |
| 2022-01-05 | 16 | $160 | $90 | $126.538 | $122.69 | 3.14% |
| 2022-01-11 | 13 | $160 | $90 | $128.083 | $122.69 | 4.4% |
| 2022-01-19 | 14 | $160 | $90 | $128.083 | $122.69 | 4.4% |
| 2022-01-26 | 14 | $160 | $92 | $126.833 | $122.69 | 3.38% |
| 2022-02-09 | 14 | $160 | $71 | $125.083 | $122.69 | 1.95% |
| 2022-03-04 | 13 | $150 | $71 | $121.909 | $122.69 | -0.64% |
| 2022-03-07 | 13 | $150 | $80 | $122.727 | $122.69 | 0.03% |
| 2022-03-16 | 13 | $150 | $80 | $123 | $122.69 | 0.25% |
| 2022-04-04 | 13 | $150 | $80 | $124.3 | $122.69 | 1.31% |
| 2022-04-12 | 13 | $150 | $77 | $124 | $122.69 | 1.07% |
| 2022-04-20 | 13 | $150 | $77 | $124.2 | $122.69 | 1.23% |
| 2022-05-09 | 13 | $150 | $77 | $124.1 | $122.69 | 1.15% |
| 2022-05-13 | 13 | $150 | $77 | $124.6 | $122.69 | 1.56% |
| 2022-05-18 | 13 | $150 | $74 | $124.3 | $122.69 | 1.31% |
| 2022-05-24 | 14 | $155 | $74 | $127.09 | $122.69 | 3.59% |
| 2022-06-22 | 13 | $155 | $74 | $127.09 | $122.69 | 3.59% |
| 2022-07-25 | 13 | $155 | $80 | $126.272 | $122.69 | 2.92% |
| 2022-07-29 | 13 | $162 | $80 | $127.363 | $122.69 | 3.81% |
| 2022-08-03 | 13 | $162 | $80 | $127.583 | $122.69 | 3.99% |
| 2022-08-04 | 13 | $162 | $100 | $132.076 | $122.69 | 7.65% |
| 2022-08-09 | 13 | $182 | $100 | $133.769 | $122.69 | 9.03% |
| 2022-08-13 | 13 | $182 | $100 | $134.923 | $122.69 | 9.97% |
| 2022-09-06 | 13 | $182 | $100 | $136.461 | $122.69 | 11.22% |
| 2022-09-07 | 13 | $182 | $100 | $137.461 | $122.69 | 12.04% |
| 2022-09-14 | 13 | $182 | $114 | $140.153 | $122.69 | 14.23% |
| 2022-10-03 | 12 | $182 | $114 | $141.416 | $122.69 | 15.26% |
| 2022-10-12 | 12 | $182 | $114 | $141.916 | $122.69 | 15.67% |
| 2022-10-20 | 12 | $182 | $114 | $143.5 | $122.69 | 16.96% |
| 2022-10-21 | 12 | $182 | $114 | $144 | $122.69 | 17.37% |
| 2022-11-25 | 12 | $190 | $114 | $146.153 | $122.69 | 19.12% |
| 2022-12-02 | 12 | $190 | $114 | $146.846 | $122.69 | 19.69% |
| 2022-12-19 | 13 | $190 | $114 | $147.642 | $122.69 | 20.34% |
| 2022-12-22 | 14 | $190 | $114 | $148.466 | $122.69 | 21.01% |
| 2022-12-29 | 14 | $190 | $114 | $150.066 | $122.69 | 22.31% |
| 2023-01-04 | 15 | $190 | $114 | $151.533 | $122.69 | 23.51% |
| 2023-01-10 | 15 | $190 | $114 | $151.666 | $122.69 | 23.62% |
| 2023-01-16 | 15 | $190 | $122 | $152.4 | $122.69 | 24.22% |
| 2023-02-27 | 15 | $190 | $122 | $153.4 | $122.69 | 25.03% |
| 2023-03-01 | 16 | $190 | $122 | $154.933 | $122.69 | 26.28% |
| 2023-03-02 | 16 | $226 | $122 | $169 | $122.69 | 37.75% |
| 2023-03-09 | 16 | $226 | $122 | $172.533 | $122.69 | 40.63% |
The Trend in the Analyst Price Target
SRPT's average price target has moved down $25.42 over the prior 33 months.
Over the past 49 weeks, SRPT's average upside potential has been 33.98%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-12 | 13 | 150 | 77 | 124.000 | 82.34 | 50.6% |
| 2022-08-13 | 13 | 182 | 100 | 134.923 | 109.00 | 23.78% |
| 2022-09-07 | 13 | 182 | 100 | 137.461 | 112.90 | 21.75% |
| 2022-12-22 | 14 | 190 | 114 | 148.466 | 132.13 | 12.36% |
| 2023-01-10 | 15 | 190 | 114 | 151.666 | 119.13 | 27.31% |
SRPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 12 | 2 | 2 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 13 months, SRPT's average broker recommendation rating improved by 0.05.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SRPT as an investment opportunity.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAREPTA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 485.36% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAREPTA THERAPEUTICS INC's average analyst price target is greater than 4303.4% of them.
- SAREPTA THERAPEUTICS INC's number of analysts covering the stock is higher than 4170.81% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the large market cap category, SAREPTA THERAPEUTICS INC's variance in analysts' estimates is lower than -2987.33% of them.
Stocks similar to SAREPTA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are REGN, BMY, and RPRX.
View All Top Stocks by Price Target
What is the outlook for SRPT? Use POWR Ratings for clearer insight into price direction.